The timing of our webinar is very deliberate. On January 11, we will be one year and one day from the full implementation of the EU HTA Regulation for oncology products, ATMPs and certain medical devices. How prepared are you feeling?
Join us for a whistle-stop tour of what we know about the regulation so far and how biopharmaceutical companies should be preparing.
During this webinar, we will cover:
- EU HTA regulation progress to date
- The impact at a Member State level
- How pharmaceutical companies should be preparing
- The intersection of the EU HTA Regulation and draft EU pharmaceutical legislation
Join Suzette Matthijsse, Senior Director and EU Head of Modelling & Analytics, and independent access consultant, Neil Grubert, as they discuss important updates and how to best prepare for the EU HTA regulation. There will also be time for questions with our presenters. We look forward to you joining us.
January 11, 2:00pm GMT